Point-of-Use
Device Development
from Concept
to Commercialization

End-to-End Integrated Services for
Complete Point-of-Use IVD Devices

Assay Development

From concept to commercialization, DCN Dx helps clients develop every aspect of today's high-performance point-of-use in vitro diagnostics.

Assay Development

From concept to commercialization, DCN Dx helps clients develop every aspect of today's high-performance point-of-use diagnostics.
LEARN MORE >

Platform Solutions

Modern rapid point-of-use testing requires high-performance sample collection devices, cartridges, and reader systems. DCN Dx delivers them.

Platform Solutions

Modern rapid point-of-use testing requires high-performance sample collection devices, cartridges, and reader systems. DCN Dx delivers them.
LEARN MORE >

Contract Manufacturing

Whether it's a few thousand units or a few million, DCN Dx's flexible, scalable solutions for manufacturing ensure your needs are met when you need it.

Contract Manufacuring

Whether it's a few thousand units or a few million, DCN Dx's flexible, scalable solutions for manufacturing ensure your needs are met when you need it.
LEARN MORE >

Clinical Research Services

DCN Dx develops and executes comprehensive evidence plans that are fully integrated with your assay's design and commercialization strategy.

Clinical Research Services

DCN Dx develops and executes comprehensive evidence plans that are fully integrated with your assay's design and commercialization strategy.
LEARN MORE >
lateral flow cassette, lateral flow assay cassette, DCN Dx, cassette design, assay development, test performance, functionality, mold design, closure process, rapid prototype, user-centric, application-centric, DCNovations LFI Cassette, lateral flow device, lateral flow test, flow patterns, test strip integration, cost-effective, high-performance

DCN Dx empowers the creation of in vitro diagnostic tools that:

  • Enable individuals to monitor their own health
  • Help health organizations identify outbreaks of infectious disease
  • Facilitate faster delivery of life-saving drugs
  • Keep soldiers healthy
  • Increase food production without harmful chemicals
  • And more

Products

DCN Dx’s DCNovations product line is designed to help you develop high-performance point-of-use diagnostic assays in your own facility.

We’re Hiring!

Discover DCN Dx Employment Opportunities

What's New

Press releases

DCN Dx Bolsters Board with Appointment of Former Meridian Biosciences CEO Jack Kenny

CARLSBAD, Calif.—DCN Dx, a global leader in the end-to-end development, manufacturing, and commercialization of point-of-use tests, announces the appointment of industry veteran Jack Kenny to...

Articles

Flow Forward at ALFC 2024: Embracing Future Innovations and Collaborations in Lateral Flow

Press releases

Advanced Lateral Flow Conference 2024 Agenda Now Available for Download

Contact Us

DCN Dx

3193 Lionshead Ave, Suite 200
Carlsbad, CA 92010 USA

1 (760) 804-3886​
info@dcndx.com

PortaCheck (A DCN Dx Brand)

portacheck.com

1388 Antelope Road
White City, OR 97503

1 (800) 964-6466
info@portacheck.com

Biomed Diagnostics (A DCN Dx Brand)

biomeddiagnostics.com

1388 Antelope Road
White City, OR 97503

1 (800) 964-6466
sales@biomeddiagnostics.com

CEO @ Gravidas Diagnostics

As a company led by physicians and entrepreneurs, we found a great development partner in DC. Our partnership helped us save an immense amount of time, provided high-quality development expertise and data outputs.

Nirdesh K. Gupta, Ph.D.
CEO - Gravidas Diagnostics

CEO @ Mainz Biomed

We're thrilled to have engaged with the outstanding clinical research team at DCN Dx. Their remarkable skill in designing and managing clinical trials, particularly for molecular genetic diagnostic tests in development, is invaluable.

Guido Baechler
CEO - Mainz Biomed
svgviewer png output

Sr. Program Manager @ SRI International

RI and DCN have successfully partnered on three U.S. Government-funded IV medical device projects. DCN has been an innovative and responsive collaborator, prototyping complex assays and advising on appropriate analyzers.

Will Brubaker
Sr. Program Manager - SRI International
uh oh labs logo

President & Chief Business Officer @ Scout

Our experience with DCN has been nothing short of outstanding. Their deep understanding of diagnostics, especially in the molecular realm, was exactly what we needed. Their team stood out with excellent communication, flexibility, and responsiveness, meeting our needs at every turn.

Alex Jiao, Ph.D.
President & Chief Business Officer - Scout

Testimonial from the CEO of FABPulous

The experience, expertise, and expert network of DCN Dx has allowed FABPulous to transform a novel technology concept into a simple, easy, and intuitive-to-use product, where truly "form follows function."

Diederik Engberson
CEO, FABPulous, Maastricht, The Netherlands
point of care testing,POC testing, point-of-care testing, rapid diagnostics, rapid diagnostic, lateral flow, lateral flow assay, infectious disease diagnostic testing, what is a diagnostic test?, what is a rapid diagnostic test?, what is a lateral flow test?, dcn dx, dcn diagnostics, brendan o'farrell, rapid diagnostic test, what is a rapid diagnostic, what is lateral flow, point-of-need testing, immunoassay, sample collection, sample prep, microfluidics, lateral flow test

Testimonial from the CEO of Invisible Sentinel

DCN was a tremendous resource for our assay development needs. [Their team leader] is one of the foremost experts in the field, and his knowledge and expertise contributed to the successful development of our patented flow-based detection system, Veriflow™.

Nicholas A. Siciliano
CEO, Invisible Sentinel, Inc., MA USA